Connection

Christoph Correll to Liraglutide

Back to Details
This is a "connection" page, showing publications Christoph Correll has written about Liraglutide.
Christoph Correll
Connection Strength
0.387
Liraglutide
  1. Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain-Reply. JAMA Psychiatry. 2017 11 01; 74(11):1173-1174.
    View in: PubMed
    Score: 0.173
  2. Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2017 07 01; 74(7):719-728.
    View in: PubMed
    Score: 0.169
  3. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis. Diabetes Obes Metab. 2019 02; 21(2):293-302.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.